S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Sell every Stock except ONE (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Sell every Stock except ONE (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Sell every Stock except ONE (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Sell every Stock except ONE (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Sell every Stock except ONE (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Sell every Stock except ONE (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Sell every Stock except ONE (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
Sell every Stock except ONE (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Sell every Stock except ONE (Ad)
North Korea notifies neighboring Japan it plans to launch satellite in coming days
Sleepless in Kyiv: Nighttime Russian air campaign terrorizes citizens in Ukrainian capital
NASDAQ:TXMD

TherapeuticsMD (TXMD) Short Interest Ratio & Short Volume

$3.86
+0.02 (+0.52%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$3.79
$3.98
50-Day Range
$3.42
$4.49
52-Week Range
$2.02
$11.69
Volume
19,400 shs
Average Volume
40,952 shs
Market Capitalization
$39.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TherapeuticsMD Short Interest Data

Current Short Volume
312,600 shares
Previous Short Volume
342,400 shares
Change Vs. Previous Month
-8.70%
Dollar Volume Sold Short
$1.37 million
Short Interest Ratio / Days to Cover
8.1
Last Record Date
May 15, 2023
Outstanding Shares
10,135,000 shares
Float Size
9,420,000 shares
Short Percent of Float
3.32%
Today's Trading Volume
19,400 shares
Average Trading Volume
40,952 shares
Today's Volume Vs. Average
47%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling TherapeuticsMD ?

Sign up to receive the latest short interest report for TherapeuticsMD and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TXMD Short Interest Over Time

TXMD Days to Cover Over Time

TXMD Percentage of Float Shorted Over Time


TherapeuticsMD (NASDAQ:TXMD) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2023312,600 shares $1.37 million -8.7%3.3%8.1 $4.39
4/30/2023342,400 shares $1.21 million +3.5%3.7%10 $3.54
4/15/2023330,900 shares $1.20 million +4.3%3.6%8.8 $3.62
3/31/2023317,200 shares $1.19 million +20.2%3.4%8 $3.75
3/15/2023263,800 shares $962,870.00 +10.4%3.0%5.5 $3.65
2/28/2023239,000 shares $1.19 million -11.2%2.7%1.9 $4.96
2/15/2023269,000 shares $1.38 million -5.4%3.2%2.1 $5.13
1/31/2023284,400 shares $1.50 million -12.1%3.2%2.1 $5.27
1/15/2023323,500 shares $1.75 million -4.1%3.8%2.4 $5.40
12/30/2022337,200 shares $1.88 million -26.2%4.0%2.5 $5.59
12/15/2022457,000 shares $3.03 million +46.8%5.4%3.4 $6.63
11/30/2022311,300 shares $1.43 million -19.5%3.7%2.4 $4.58
11/15/2022386,500 shares $2.29 million +12.9%4.6%5.4 $5.93
10/31/2022342,400 shares $2.17 million +2.4%4.1%2.7 $6.33
10/15/2022334,400 shares $2.15 million -3.3%4.0%1.2 $6.44
9/30/2022345,900 shares $2.30 million -5.9%4.2%0.8 $6.64
9/15/2022367,600 shares $2.87 million -11.2%4.4%0.6 $7.80
8/31/2022413,800 shares $4.10 million -33.3%5.0%0.5 $9.91
8/15/2022620,700 shares $5.74 million -32.6%8.0%0.6 $9.24
7/31/2022921,100 shares $5.74 million +38.6%11.9%0.6 $6.23
7/15/2022664,500 shares $3.95 million +65.7%8.6%0.5 $5.94
6/30/2022401,000 shares $3.99 million -28.3%5.2%0.3 $9.95
6/15/2022559,600 shares $5.55 million -72.2%7.4%0.5 $9.92
5/31/20222,010,000 shares $19.96 million +36.7%26.4%2.2 $9.93
5/15/20221,470,000 shares $4.51 million +94.1%19.3%2.2 $3.07
4/30/2022757,300 shares $7.64 million -97.6%10.0%4.3 $10.09
4/15/202231,900,000 shares $9.25 million +2.8%8.4%4.5 $0.29
3/31/202231,030,000 shares $11.79 million -2.6%8.2%4.7 $0.38
3/15/202231,870,000 shares $10.37 million +28.6%N/A4.1 $0.33
2/28/202224,790,000 shares $5.93 million -2.4%N/A3.3 $0.24
2/15/202225,410,000 shares $6.68 million +11.6%N/A3.8 $0.26
1/31/202222,760,000 shares $6.92 million -10.2%N/A3.4 $0.30
1/15/202225,350,000 shares $8.75 million +35.2%N/A4.1 $0.35
12/31/202118,750,000 shares $6.67 million -29.4%N/A3.2 $0.36
12/15/202126,550,000 shares $10.78 million -20.0%N/A5.7 $0.41
11/30/202133,180,000 shares $16.42 million +9.9%N/A6.9 $0.50
11/15/202130,180,000 shares $18.50 million +3.6%N/A7 $0.61
10/29/202129,130,000 shares $21.21 million +2.5%N/A6.3 $0.73
10/15/202128,430,000 shares $20.49 million -1.6%N/A5.7 $0.72
9/30/202128,890,000 shares $21.42 million +0.7%N/A5.6 $0.74













TXMD Short Interest - Frequently Asked Questions

What is TherapeuticsMD's current short interest?

Short interest is the volume of TherapeuticsMD shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 312,600 shares of TXMD short. 3.32% of TherapeuticsMD's shares are currently sold short. Learn More on TherapeuticsMD's current short interest.

What is a good short interest ratio for TherapeuticsMD?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TXMD shares currently have a short interest ratio of 8.0. Learn More on TherapeuticsMD's short interest ratio.

Which institutional investors are shorting TherapeuticsMD?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of TherapeuticsMD: Group One Trading L.P., PEAK6 Investments LLC, XR Securities LLC, Equitec Proprietary Markets LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for TherapeuticsMD?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.32% of TherapeuticsMD's floating shares are currently sold short.

Is TherapeuticsMD's short interest increasing or decreasing?

TherapeuticsMD saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 312,600 shares, a decrease of 8.7% from the previous total of 342,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is TherapeuticsMD's float size?

TherapeuticsMD currently has issued a total of 10,135,000 shares. Some of TherapeuticsMD's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TherapeuticsMD currently has a public float of 9,420,000 shares.

How does TherapeuticsMD's short interest compare to its competitors?

3.32% of TherapeuticsMD's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to TherapeuticsMD: Atreca, Inc. (9.13%), Rain Oncology Inc. (6.20%), Corbus Pharmaceuticals Holdings, Inc. (3.36%), Unity Biotechnology, Inc. (7.39%), Biora Therapeutics, Inc. (3.45%), NuCana plc (0.18%), SELLAS Life Sciences Group, Inc. (4.41%), NRx Pharmaceuticals, Inc. (3.16%), Medicenna Therapeutics Corp. (0.69%), BeyondSpring Inc. (9.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.29 billion), T-Mobile US, Inc. ($4.17 billion), Charter Communications, Inc. ($3.07 billion), Occidental Petroleum Co. ($2.81 billion), Moderna, Inc. ($2.37 billion), Coinbase Global, Inc. ($2.27 billion), T. Rowe Price Group, Inc. ($1.98 billion), Verisk Analytics, Inc. ($1.94 billion), Extra Space Storage Inc. ($1.88 billion), and Xylem Inc. ($1.61 billion). View all of the most shorted stocks.

What does it mean to sell short TherapeuticsMD stock?

Short selling TXMD is an investing strategy that aims to generate trading profit from TherapeuticsMD as its price is falling. TXMD shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against TherapeuticsMD?

A short squeeze for TherapeuticsMD occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TXMD, which in turn drives the price of the stock up even further.

How often is TherapeuticsMD's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TXMD, twice per month. The most recent reporting period available is May, 15 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:TXMD) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -